CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis C$0.03 -0.01 (-14.29%) As of 11:01 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartInsider TradesBuy This Stock About Quest PharmaTech Stock (CVE:QPT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Quest PharmaTech alerts:Sign Up Key Stats Today's RangeC$0.03▼C$0.0350-Day RangeC$0.03▼C$0.0452-Week RangeC$0.03▼C$0.05Volume7,000 shsAverage Volume41,621 shsMarket CapitalizationC$5.07 millionP/E RatioN/ADividend Yield6.15%Price TargetN/AConsensus RatingN/A Company Overview Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. Read More Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QPT Stock News HeadlinesQuest PharmaTech Inc.: Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual BasisMay 31, 2026 | finanznachrichten.deQuest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual BasisMay 29, 2026 | financialpost.comFRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.June 10 at 1:00 AM | Porter & Company (Ad)Quest PharmaTech Strengthens Board and Grants Stock Options at AGMAugust 27, 2025 | tipranks.comQuest PharmaTech Inc. (QPT.V) - Yahoo FinanceJuly 8, 2025 | ca.finance.yahoo.comQuest PharmaTech Inc. (QPTFF) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comQuest PharmaTech Inc.: Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTechJune 11, 2025 | finanznachrichten.deQuest PharmaTech Strengthens Stake in Cancer ImmunotherapyJune 2, 2025 | tipranks.comSee More Headlines QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed this year? Quest PharmaTech's stock was trading at C$0.04 at the start of the year. Since then, QPT stock has decreased by 14.3% and is now trading at C$0.03. How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athersys (ATHX) and Antibe Therapeutics (ATE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.00 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.88 million Net MarginsN/A Pretax MarginN/A Return on Equity-6.28% Return on Assets-1.07% Debt Debt-to-Equity Ratio4.35 Current Ratio0.40 Quick Ratio0.52 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.14 per share Price / Book0.21Miscellaneous Outstanding Shares169,129,000Free FloatN/AMarket CapC$5.07 million OptionableNot Optionable Beta-0.09 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (CVE:QPT) was last updated on 6/10/2026 by MarketBeat.com Staff. From Our PartnersNo. You’re not imagining it…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour name isn't on our protected list yetI checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...American Alternative | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredLive demo of Elon Musk’s AI agentJeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's...Brownstone Research | SponsoredImportant SpaceX PREDICTIONThe biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian s...Banyan Hill Publishing | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredTesla. SolarCity. Twitter. This $4 stock is next.Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
